Pharmacotherapy for older people with obesity
- 18 June 2024
- journal article
- review article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 130, 33-37
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or ObesityJAMA, 2021
- Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or ObesityJAMA, 2021
- Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohortJournal of Cachexia, Sarcopenia and Muscle, 2020
- Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5Obesity, 2020
- The Potential of β-Hydroxy-β-Methylbutyrate as a New Strategy for the Management of Sarcopenia and Sarcopenic ObesityDrugs & Aging, 2017
- Does Diet-Induced Weight Loss Lead to Bone Loss in Overweight or Obese Adults? A Systematic Review and Meta-Analysis of Clinical TrialsJournal of Bone and Mineral Research, 2015
- Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index CategoriesJAMA, 2013
- Effects of weight loss on ventricular systolic and diastolic functions and left ventricular mass assessed by tissue doppler imaging in obese geriatric women: preliminary reportAging Clinical and Experimental Research, 2010
- The danger of weight loss in the elderlyThe Journal of nutrition, health and aging, 2008
- Orlistat in the Long-term Treatment of Obesity in Primary Care SettingsArchives of Family Medicine, 2000